Cabaletta Bio (CABA) EBIT (2018 - 2025)
Cabaletta Bio's quarterly EBIT came in at -$42.6 million in Q4 2025, down 26.12% year-on-year from -$57.7 million in Q4 2024, and up 8.54% quarter-over-quarter from -$46.6 million in Q3 2025.
Cabaletta Bio has reported EBIT for 8 years, with the latest figure at -$42.6 million in Q4 2025.
- For the quarter ending Q4 2025, EBIT fell 26.12% year-over-year to -$42.6 million; the trailing twelve-month figure through Dec 2025 stood at -$172.2 million (down 37.64% YoY), and the FY2025 full-year result was -$172.2 million, down 37.64% from the prior year.
- EBIT for Q4 2025 stood at -$42.6 million, up from -$46.6 million in the prior quarter.
- The five-year high for EBIT was -$9.7 million in Q1 2021, with the low at -$46.6 million in Q3 2025.
- Average EBIT over 5 years is -$23.6 million, with a median of -$17.8 million recorded in 2023.
- Year-over-year, EBIT slipped 1.86% in 2022 and plunged 90.55% in 2024.
- Tracing CABA's EBIT over 5 years: stood at -$13.9 million in 2021, then retreated by 17.34% to -$16.3 million in 2022, then sank by 41.98% to -$23.1 million in 2023, then tumbled by 45.96% to -$33.8 million in 2024, then fell by 26.12% to -$42.6 million in 2025.
- The last three EBIT figures came in at -$42.6 million (Q4 2025), -$46.6 million (Q3 2025), and -$45.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | -42.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42.61 Mn |
| Sep 30, 2025 | -46.59 Mn |
| Jun 30, 2025 | -45.91 Mn |
| Mar 31, 2025 | -37.14 Mn |
| Dec 31, 2024 | -33.79 Mn |
| Sep 30, 2024 | -33.05 Mn |
| Jun 30, 2024 | -30.28 Mn |
| Mar 31, 2024 | -28.03 Mn |
| Dec 31, 2023 | -23.15 Mn |
| Sep 30, 2023 | -18.67 Mn |
| Jun 30, 2023 | -15.89 Mn |
| Mar 31, 2023 | -16.96 Mn |
| Dec 31, 2022 | -16.30 Mn |
| Sep 30, 2022 | -11.78 Mn |
| Jun 30, 2022 | -13.06 Mn |
| Mar 31, 2022 | -13.00 Mn |
| Dec 31, 2021 | -13.89 Mn |
| Sep 30, 2021 | -11.56 Mn |
| Jun 30, 2021 | -11.15 Mn |
| Mar 31, 2021 | -9.71 Mn |
| Dec 31, 2020 | -9.33 Mn |
| Sep 30, 2020 | -8.42 Mn |
| Jun 30, 2020 | -8.19 Mn |
| Mar 31, 2020 | -7.90 Mn |
| Dec 31, 2019 | -5.86 Mn |
| Sep 30, 2019 | -5.03 Mn |
| Jun 30, 2019 | -3.80 Mn |
| Mar 31, 2019 | -3.99 Mn |
| Dec 31, 2018 | -2.07 Mn |
| Sep 30, 2018 | -3.08 Mn |